Agency Resources and Planned Performance - Health

501

NH

MR

C

NATIONAL HEALTH AND MEDICAL

RESEARCH COUNCIL

Agency Resources and Planned Performance

502

503

NH

MR

C

National Health and Medical Research Council

Health and Ageing Portfolio Agency

Section 1: Agency Overview and Resources

1.1: Strategic Direction Statement ................................................................ 504

1.2: Agency Resource Statement ................................................................. 505

1.3: Budget Measures .................................................................................. 506

Section 2: Outcomes and Planned Performance

2.1: Outcomes and Performance Information ............................................... 507

Section 3: Explanatory Tables and Budgeted Financial Statements

3.1: Explanatory Tables ............................................................................... 512

3.2: Budgeted Financial Statements ............................................................. 513

NHMRC - Agency Budget Statements – Budgeted Financial Statements

504

Section 1: Agency Overview and Resources

1.1 Strategic Direction Statement

The National Health and Medical Research Council (NHMRC) is the Australian Government’s key agency for managing investment in health and medical research. NHMRC is also responsible for developing evidence-based health advice for the Australian community, health professionals and governments, and for providing advice on ethical practice in health care and in the conduct of health and medical research.

The role and functions of NHMRC are set out in the National Health and Medical Research Council Act (1992). NHMRC also has statutory obligations under the Prohibition of Human Cloning for Reproduction Act (2002) and the Research Involving Human Embryos Act (2002). NHMRC is prescribed as an agency under the Financial Management and Accountability Act (1997).

NHMRC - Agency Budget Statements – Agency Overview and Resources

505

NH

MR

C

1.2 Agency Resources

Table 1.2.1 shows the total resources from all origins. The table summarises how resources will be applied by outcome and by Departmental classifications.

Table 1.2.1 NHMRC Resource Statement – Budget Estimates for 2013-14 as at Budget May 2013

Estimate of prior year

amounts available in

2013-14 $'000

Proposed at Budget

2013-14 $'000

Total estimate

2013-14 $'000

Estimated available

appropriation

2012-13 $'000

Ordinary annual services1

Departmental appropriation

Prior year departmental appropriation2 13,005 - 13,005 16,369

Departmental appropriation3 - 40,273 40,273 39,944

s31 Relevant agency receipts - 3,150 3,150 3,150

Total 13,005 43,423 56,428 59,463

Administered resources1

Outcome 1 - 783,640 783,640 697,165

Total - 783,640 783,640 697,165

Total ordinary annual services 13,005 827,063 840,068 756,628

Other services - Bill 24

Departmental non-operating

Equity injections - - - -

Total - - - -

Total other services - - - -

Total available annual appropriations 13,005 827,063 840,068 756,628

Total appropriations excluding Special Accounts 13,005 827,063 840,068 756,628

Special Accounts

Opening balance5 206,764 - 206,764 267,396

Appropriation receipts6 - 771,187 771,187 689,326

Non-appropriation receipts to Special Accounts - 11,050 11,050 11,050

Total Special Accounts 206,764 782,237 989,001 967,772

Total resourcing 219,769 1,609,300 1,829,069 1,724,400

Less appropriations drawn from annual or special appropriations above and credited to Special Accounts and/or CAC Act bodies through annual appropriations - (771,187) (771,187) (689,326)

Total net resourcing for NHMRC 219,769 838,113 1,057,882 1,035,074

Notes:

All figures are GST exclusive. 1 Appropriation Bill (No.1) 2013-14. 2 Estimated adjusted balance carried from previous year for annual appropriations. 3 Includes an amount of $.082m in 2013-14 for the Departmental Capital Budget (refer to Table 3.2.5 for further

details). For accounting purposes this amount has been designated as 'contributions by owners'. 4 Appropriation Bill (No.2) 2013-14. 5 Estimated opening balance for special accounts. For further information on special accounts see Table 3.1.2. 6 Appropriation receipts from NHMRC annual and special appropriations for 2013-14 included above.


506

1.3 Budget Measures

Budget measures relating to NHMRC are detailed in Budget Paper No. 2 and are summarised below.

Table 1.3.1: NHMRC Budget Measures

Part 1: Measures announced since the 2012-13 MYEFO

Program 2012-13 2013-14 2014-15 2015-16 2016-17

$'000 $'000 $'000 $'000 $'000

Acute rheumatic fever vaccine - research


Administered expenses 1.1 - 600 730 - -

Departmental expenses - 33 60 - -

Total - 633 790 - -

Other Portfolio Measures

A Plan for Australian Jobs - Clinical Trials Reform in Australia


Administered expenses 1.1 - 680 306 281 284

Departmental expenses - 442 759 768 774

Total - 1,122 1,065 1,049 1,058

Part 2: MYEFO measures not previously reported in a portfolio statement

Whole of Government Measures

Targeted savings - public service efficiencies1


Departmental expenses 1.1 (533) (698) (699) (703) (688)

Total (533) (698) (699) (703) (688)

1 Measure reported incudes amounts previously reported in the Health and Ageing 2012-13 Portfolio Additional Estimate Statements (page 25).


507

NH

MR

C

Section 2: Outcomes and Planned Performance

2.1 Outcomes and Performance Information

Outcome 1 – Improved health and medical knowledge, including through funding research, translating research findings into evidence-based clinical practice, administering legislation governing research, issuing guidelines and advice

for ethics in health and the promotion of public health

Outcome Strategy

The Australian Government, through NHMRC, invests in health and medical research that is undertaken within a well-established ethical framework, to address national health priorities and improve the health status of all Australians.

Health and medical research is vital in driving improvements throughout the health system. It also supports the development of rigorous, evidence-based advice for both health practitioners and the Australian community.

The Australian Government, through NHMRC, will build Australia’s research capacity and international standing by investing in innovative research, and the individuals and facilities needed to support such research. NHMRC’s work will also facilitate the translation of evidence derived from health and medical research into practices and systems designed to prevent illness and improve public health.

It can take more than 20 years for knowledge, created through research, to be translated into health interventions and applied in clinical settings. 1 This means that the Government’s investment in health and medical research produces benefits for the Australian community well into the future.

NHMRC will maximise this investment through collaboration with regional neighbours to address common health challenges and, more widely, to facilitate access by Australian researchers and health professionals to sources of international funding and the best collaborative networks and research facilities. Engaging with international research partners provides opportunities for Australia to be involved in developing international policies and initiatives in research governance, and explore emerging fields of health and medical research for the benefit of all Australians. The NHMRC Strategic Plan 2013-20152 identifies the priorities for NHMRC to achieve these outcomes.

1 Trochim W, Kane C, Graham M, Pincus H. - Evaluating Translational Research: A Process Marker Model. In: Clinical

and Translation Science, 2011,Volume 4 – Issue 3, pp. 153-162.

2 Available at: www.nhmrc.gov.au


508

NHMRC Budgeted Expenses and Resources

Table 2.1.1 provides an overview of the total expenses for NHMRC by Program.

Table 2.1.1: Budgeted Expenses and Resources for NHMRC

2012-13 Estimated

actual $'000

2013-14 Budget

$'000

2014-15 Forward

year 1 $'000

2015-16 Forward

year 2 $'000

2016-17 Forward

year 3 $'000

Program 1.1: Health and medical research

Administered expenses

Ordinary annual services 697,165 783,640 872,259 811,845 826,458 to the Medical Research

Endowment Account (689,326) (771,187) (859,870) (800,222) (814,627)

Special accounts Medical Research Endowment

Account 761,008 858,576 930,902 859,737 839,792

Departmental expenses

Departmental appropriation1 43,013 43,341 43,939 44,228 44,653

Expenses not requiring appropriation in the budget year

2 1,901 1,901 1,901 1,901 1,901

Operating deficit (surplus) 1,400 1,400 1,400 - -

Total for Program 1.1 815,161 917,671 990,531 917,489 898,177

Total expenses for Outcome 1 815,161 917,671 990,531 917,489 898,177

2012-13 2013-14 Average staffing level (number) 215 217

1 Departmental appropriation combines "Ordinary annual services (Appropriation Bill No 1)" and "Revenue from independent sources (s31)".

2 Expenses not requiring appropriation in the Budget year is made up of depreciation expense, amortisation

expense, makegood expense and audit fees.


509

NH

MR

C

Program 1.1: Health and medical research

Program Objectives

Support high quality health and medical research

In 2013-14, NHMRC will implement two new measures to support essential research in Australia.

Over 4 years, NHMRC will, in conjunction with the Department of Innovation, Industry, Climate Change, Science, Research and Tertiary Education (DIICCSRTE) and agencies within the Health Portfolio, conduct work to better support the clinical trials sector in Australia. This work will build on that previously completed in response to the recommendations of the Clinical Trials Action Group Report. It will enable NHMRC to work with the states and territories and other stakeholders on the continued implementation of a nationally consistent approach to streamlining research governance and ethics review arrangements for clinical trials in the public and private sectors.

In addition, NHMRC will develop education, guidance and support for clinical trials proponents for the preparation and submission of applications for ethics and governance approval. Finally, the initiative will allow NHMRC in conjunction with DIICCSRTE to work on the development of a national interactive portal to enable greater participation and engagement in clinical trials.

In recognition that Australia has the highest documented rate of Group A Streptococcus (GAS disease) internationally,3 NHMRC will also implement a new initiative conjointly with its counterpart, the Health Research Council (HRC) of New Zealand to develop a vaccine. One of the critical impacts of GAS disease for affected Indigenous peoples is its contribution to their burden of shorter lifespan. An effective vaccine would contribute to the overall efforts in the Australian health sector to Close the Gap.

The Australian Government, through NHMRC, will build Australia’s research capacity and international standing by supporting both people and facilities undertaking innovative research. Through the Medical Research Endowment Account,4 NHMRC will award grants through a number of funding schemes to support research in all areas of health, targeting special areas of need such as Aboriginal and Torres Strait Islander health.

Support the translation of health and medical research

The Australian Government recognises the importance of translating research to drive improvements throughout the health system. In 2013-14, NHMRC will commence work with its new Research Translation Faculty to identify the most important evidence gaps in major health issues and develop evidence-based actions to address them. NHMRC will also develop evidence-based health advice

3 Source: Carapetis, J.R., A.C. Steer et al. (2005) ‘The global burden of group A streptococcal diseases’. Lancet Infect

Dis 5(11):685-694. 4 The Medical Research Endowment Account is a special account established under the National Health and Medical

Research Council Act (1992). Payments are made from the account to government departments, universities, institutions or people engaged in medical research and for assistance in training people in medical research.


510

and guidelines in areas such as lead (safe blood levels), alternative therapies, windfarms and health, and genomics.

Promote the highest ethical standards in health and medical research

The Australian Government is committed to ensuring that the health and medical research undertaken in Australia is of the highest ethical standard. In 2013-14, NHMRC will monitor funding recipients to ensure they comply with the Australian Code for the Responsible Conduct of Research (2007). NHMRC will advise human

research ethics committees that undertake the ethical review of research involving humans and monitor the conduct of research, as well as provide advice to institutions and researchers. NHMRC will also encourage the continued uptake of the National Approach to Single Ethical Review initiative (formerly known as the Harmonisation of Multi-centre Ethical Review (HoMER)) within public and private hospitals and in universities. NHMRC will revise sections of the National Statement on Ethical Conduct in Human Research 2007, Part B of the Ethical Guidelines on the use of Assisted Reproductive Technology in Clinical Practice and Research, June 2007 and finalise the revision of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 2004.

NHMRC will continue to administer the Research Involving Human Embryos Act (2002) and the Prohibition of Human Cloning for Reproduction Act (2002). These Acts prohibit certain practices, including human cloning for reproduction and restrict other practices relating to reproductive technology and research.

Program 1.1: Deliverables

Qualitative Deliverable for Program 1.1


Qualitative Deliverable 2013-14 Reference Point or Target

Funding provided for high quality research into Australian health problems

Use of targeted and urgent calls to support research into specific health problems

Quantitative Deliverables for Program 1.1


Quantitative Deliverables 2012-13 Revised Budget

2013-14 Budget Target

2014-15 Forward Year 1



Percentage of total Medical Research Endowment Account funding to the NHMRC Project Grant scheme

50% 50% 50% 50% 50%

Percentage of annual research budget awarded to Indigenous health research

>5% >5% >5% >5% >5%


511

NH

MR

C

Program 1.1: Key Performance Indicators

Qualitative Key Performance Indicators for Program 1.1


Qualitative Indicator 2013-14 Reference Point or Target

Periodic review of established funding schemes to determine strengths and identify where improvements can be made

Completed reviews are presented to Research Committee for consideration, and implemented according to established timelines


Qualitative Indicator 2013-14 Reference Point or Target

National adoption of the National Approach to Single Ethical Review initiative (formerly

known as HoMER)

Increased uptake of the National Approach to Single Ethical Review certification by Human Research Ethics Committees.

Quantitative Key Performance Indicators for Program 1.1

Support the translation of health and medical research

Quantitative Indicator

2012-13 Revised Budget





Citation rate (number of citations divided by the number of scientific publications in a given time period) of journal articles resulting from NHMRC funded research5

>50% >50% >50% >50% >50%


Quantitative Indicator

2012-13 Revised Budget





Percentage of researcher and institutional compliance with ethics codes and human embryo licensing conditions

100% 100% 100% 100% 100%

5 Bibliographic citations are where a journal article is referenced in a subsequent journal article, indicating some

scientific impact of the original work. The citation rate of journal articles resulting from NHMRC funded research (above) is compared to the world citation average, which is determined by dividing the total number of citations,

by the total number of journal articles published in the world in the same time period.


512

Section 3: Explanatory Tables and Budgeted Financial Statements

Section 3 presents explanatory tables and budgeted financial statements which provide a comprehensive snapshot of agency finances for the 2013-14 Budget year. It explains how budget plans are incorporated into the financial statements and provides further details of the reconciliation between appropriations and program expenses, movements in administered funds, special accounts and government Indigenous expenditure.

3.1 Explanatory Tables

3.1.1 Movement of administered funds between years

Table 3.1.1: Movement of Administered Funds between Years1

2012-13 2013-14 2014-15 2015-16 2016-17

$'000 $'000 $'000 $'000 $'000

Outcome 1

1.1 Health and medical research2 (74,300) - 74,300 - -

Total movement of administered funds

(74,300) - 74,300 - -

1 Figures displayed as a negative (-) represent a decrease in funds and a positive reflect an increase in funds. 2 The movement of funds for NHMRC reflects an administrative change to payment arrangements. The change to

the timing of grant payments has no impact on the current level of grant funding or existing funding

commitments, nor does it impact upon individual research projects or researchers.

3.1.2 Special Accounts

Table 3.1.2: Estimates of Special Account Flows and Balances - NHMRC

Outcome

Opening balance 2013-14 2012-13

$'000

Appropriation receipts 2013-14 2012-13

$'000

Other receipts 2013-14 2012-13

$'000

Payments

2013-14 2012-13

$'000

Closing balance 2013-14 2012-13

$'000

Medical Research 1 206,764 771,187 51,050 898,576 130,425

Endowment Account1 (A)

267,396 689,326 51,050 801,008 206,764

Total Special Accounts

2013-14 Estimate 206,764 771,187 51,050 898,576 130,425

Total Special Accounts

2012-13 estimate actual 267,396 689,326 51,050 801,008 206,764 Notes: D = Departmental; A = Administered. 1 National Health and Medical Research Council Act 1992 - s21 FMA Act.


513

NH

MR

C

3.1.3 Australian Government Indigenous Expenditure (AGIE)

Outcome Appropriations Other Total

Bill No. 1 $'000

Bill No. 2 $'000

Special appropriations

$'000

Total appropriations

$'000

$'000

$'000


Administered 2013-14 47,093 - - 47,093 - 47,093 Administered 2012-13 41,741 - - 41,741 - 41,741

Departmental 2013-14 308 - - 308 - 308

Departmental 2012-13 294 - - 294 - 294

Total outcome 2013-14 47,401 - - 47,401 - 47,401

Total outcome 2012-13 42,035 - - 42,035 - 42,035

Total AGIE 2013-14 47,401 - - 47,401 - 47,401

Total AGIE 2012-13 42,035 - - 42.035 - 42.035

3.2 Budgeted Financial Statements

3.2.1 Differences in agency resourcing and financial statements

Section 3.2.1 is not applicable to NHMRC.

3.2.2 Analysis of budgeted financial statements

An analysis of NHMRC’s budgeted financial statements for 2013-14 is set out below.

Departmental Resources

Comprehensive Income Statement (Showing Net Cost of Services)

Revenue and expenditure for 2013-14 is expected to be in line with Government forecasts, with Employee expenses to be approximately 54% of total expenditure.

Balance Sheet

The Receivables include funding for the Australia Research Fellowship scheme appropriated in 2006-07 which will be drawn down annually to facilitate the approved $1.400 million loss per annum until 30 June 2015.

Administered Resources

The Administered accounts are used as a mechanism to transfer most of the funds to NHMRC’s Special Account (Medical Research Endowment Account). In 2013-14 the transfer to the Special Account is expected to be $771.187 million. The balance of the Administered Appropriation in 2013-14 will be used to fund new measures ($1.280 million) and programs transferred from Department of Health and Ageing ($11.173 million) in the 2011-12 Budget.

In 2012-13 an initiative to change grant funding payments from quarterly in advance to monthly in arrears resulted in a re-profiling of $74.3 million from 2012-13 to 2014-15.

Expenditure in 2013-14 and forward estimates is expected to be greater than the Administered Appropriations and funds will be drawn down from the Medical Research Endowment Account.


514

3.2.3 Budgeted financial statements tables

Table 3.2.1: Comprehensive income statement (showing net cost of services) (for the period ended 30 June)

Estimated actual

2012-13 $'000

Budget estimate 2013-14

$'000

Forward estimate 2014-15

$'000


$'000


$'000

EXPENSES

Employee benefits 24,933 25,099 25,320 25,564 25,764

Supplier expenses 19,580 19,742 20,119 18,764 18,989

Depreciation and amortisation 1,801 1,801 1,801 1,801 1,801

Total expenses 46,314 46,642 47,240 46,129 46,554

LESS:

OWN-SOURCE INCOME

Revenue Sale of goods and rendering of

services 3,150 3,150 3,150 3,150 3,150

Total revenue 3,150 3,150 3,150 3,150 3,150

Gains

Other 100 100 100 100 100

Total gains 100 100 100 100 100

Total own-source income 3,250 3,250 3,250 3,250 3,250

Net cost of (contribution by) services 43,064 43,392 43,990 42,879 43,304

Revenue from Government 39,863 40,191 40,789 41,078 41,503

Surplus (Deficit) (3,201) (3,201) (3,201) (1,801) (1,801)

Surplus (Deficit) attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)

OTHER COMPREHENSIVE INCOME

Changes in asset revaluation reserves - - - - -

Total other comprehensive income - - - - -

Total comprehensive income attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)

Note: Reconciliation of comprehensive income attributable to the agency

2012-13 2013-14 2014-15 2015-16 2016-17

$'000 $'000 $'000 $'000 $'000

Total comprehensive income (loss) attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)

plus non-appropriated expenses depreciation and amortisation expenses 1,801 1,801 1,801 1,801 1,801

Total comprehensive income (loss) attributable to the agency (1,400) (1,400) (1,400) - -


515

NH

MR

C

Table 3.2.2: Budgeted Departmental balance sheet (as at 30 June)

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000

ASSETS

Financial assets

Cash and cash equivalents 343 343 343 343 343

Receivables 13,745 12,426 12,714 13,143 13,686

Total financial assets 14,088 12,769 13,057 13,486 14,029

Non-financial assets

Property, plant and equipment 6,166 5,062 3,958 2,854 1,750

Inventories 245 245 245 245 245

Intangibles 5,016 4,501 3,990 3,478 2,969

Other 94 94 94 94 94

Total non-financial assets 11,521 9,902 8,287 6,671 5,058

Total assets 25,609 22,671 21,344 20,157 19,087

LIABILITIES

Payables

Suppliers 3,461 3,461 3,461 3,461 3,461

Other payables 2,669 2,291 1,989 1,747 1,554

Total payables 6,130 5,752 5,450 5,208 5,015

Provisions

Employees 5,913 6,448 7,013 7,658 8,367

Other provisions 600 624 649 675 702

Total provisions 6,513 7,072 7,662 8,333 9,069

Total liabilities 12,643 12,824 13,112 13,541 14,084

Net Assets 12,966 9,847 8,232 6,616 5,003

EQUITY

Contributed equity 5,275 5,357 5,543 5,728 4,801

Retained surpluses or accumulated deficits 7,691 4,490 2,689 888 202

Total equity 12,966 9,847 8,232 6,616 5,003


516

Table 3.2.3: Departmental statement of changes in equity — summary of movement (Budget year 2013-14)

Retained earnings

$'000

Asset revaluation

reserve $'000

Other reserves

$'000

Contributed equity/ capital

$'000

Total equity

$'000

Opening balance as at 1 July 2013 Balance carried forward from

previous period 7,691 - - 5,275 12,966

Surplus (deficit) for the period (3,201) - - - (3,201)

Appropriation (equity injection) - - - - -

Capital budget - Bill 1 (DCB) - - - 82 82

Other movements - - - -

Estimated closing balance as at 30 June 2014 4,490 - - 5,357 9,847

DCB = Departmental Capital Budget.


517

NH

MR

C

Table 3.2.4: Budgeted Departmental statement of cash flows (for the period ended 30 June)

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000

OPERATING ACTIVITIES

Cash received

Goods and services 3,150 3,150 3,150 3,150 3,150

Appropriations 43,755 41,232 40,479 40,690 40,643

Net GST received 1,500 1,500 1,500 1,500 1,500

Total cash received 48,405 45,882 45,129 45,340 45,293

Cash used

Employees 26,574 24,564 24,755 23,963 25,055

Suppliers 19,934 21,218 20,374 21,377 20,238

Total cash used 46,508 45,782 45,129 45,340 45,293 Net cash from (or used by)

operating activities 1,897 100 - - -

INVESTING ACTIVITIES

Cash used Purchase of property, plant and

equipment 1,978

182 186 185 188

Total cash used 1,978 182 186 185 188 Net cash from (or used by)

investing activities (1,978) (182) (186) (185) (188)

FINANCING ACTIVITIES

Cash received Appropriations - contributed

equity 81

82 186 185 188

Total cash received 81 82 186 185 188 Net cash from (or used by)

financing activities 81 82 186 185 188

Net increase (or decrease) in cash held - - - - - Cash and cash equivalents at the

beginning of the reporting period 343 343 343 343 343 Cash and cash equivalents at the

end of the reporting period 343 343 343 343 343


518

Table 3.2.5: Capital budget statement

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000

CAPITAL APPROPRIATIONS

Capital budget - Bill 1 (DCB) 81 82 186 185 188

Equity injections - Bill 2 - - - - -

Total capital appropriations 81 82 186 185 188

Total new capital appropriations represented by:

Purchase of non-financial assets 81 82 186 185 188

Total items 81 82 186 185 188

PURCHASE OF NON-FINANCIAL ASSETS

Funded by capital appropriations - - - - - Funded by capital appropriation -

DCB1 81 82 186 185 188

Funded internally from departmental resources 1,897 100 - - -

Total acquisitions of non-financial assets 1,978 182 186 185 188

RECONCILIATION OF CASH USED TO ACQUIRE ASSETS TO ASSET MOVEMENT TABLE

Total purchases 1,978 182 186 185 188 Total cash used to acquire

assets 1,978 182 186 185 188

1 Does not include annual finance lease costs. Includes purchases from current and previous years' appropriation (Departmental Capital Budget).


519

NH

MR

C

Table 3.2.6: Statement of asset movements (2013-14)

Buildings

$'000

Other property, plant and

equipment $'000

Intangibles

$'000

Total

$'000

As at 1 July 2013

Gross book value - 10,505 8,272 18,777 Accumulated depreciation/amortisation

and impairment - 4,339 3,256 7,595

Opening net book balance - 6,166 5,016 11,182

CAPITAL ASSET ADDITIONS Estimated expenditure on new or

replacement assets

By purchase - appropriation equity - - - -

By purchase - appropriation

ordinary annual services - - 82 82

By purchase - other - - 100 100

Sub-total - - 182 182

Other movements

Depreciation/amortisation expense - 1,104 697 1,801

Disposals1 - - - -

Other - - - -

As at 30 June 2014

Gross book value - 10,505 8,454 18,959 Accumulated depreciation/amortisation and

impairment - 5,443 3,953 9,396

Closing net book balance - 5,062 4,501 9,563

1 Proceeds may be returned to the Official Public Account.


520

Table 3.2.7: Schedule of Budgeted Income and Expenses Administered on Behalf of Government (for the period ended 30 June)

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000 INCOME ADMINISTERED ON

BEHALF OF GOVERNMENT

Recoveries 7,000 7,000 7,000 5,000 5,000

Other non-tax revenue 4,050 4,050 3,600 3,000 3,000 Total income administered on

behalf of Government 11,050 11,050 10,600 8,000 8,000

EXPENSES ADMINISTERED ON BEHALF OF GOVERNMENT

Grants - MREA 761,008 858,576 930,902 859,737 839,792

Grants - other 7,839 12,453 12,389 11,623 11,831 Total expenses administered on

behalf of Government 768,847 871,029 943,291 871,360 851,623

Table 3.2.8: Schedule of Budgeted Assets and Liabilities Administered on Behalf of Government (as at 30 June)

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000

ASSETS ADMINISTERED ON BEHALF OF GOVERNMENT

Financial assets

Cash and cash equivalents - - - - -

Receivables 3,964 3,964 3,964 3,964 3,964

Total financial assets 3,964 3,964 3,964 3,964 3,964

Total assets administered on behalf of Government 3,964 3,964 3,964 3,964 3,964

LIABILITIES ADMINISTERED ON BEHALF OF GOVERNMENT

Payables

Grants 12,408 10,408 6,408 4,408 4,408

Total payables 12,408 10,408 6,408 4,408 4,408

Total liabilities administered on behalf of Government 12,408 10,408 6,408 4,408 4,408


521

NH

MR

C

Table 3.2.9: Schedule of Budgeted Administered Cash Flows (for the period ended 30 June)

Estimated actual

2012-13 $'000


$'000


$'000


$'000


$'000

OPERATING ACTIVITIES

Cash received

Cash Received - Other 11,050 11,050 10,600 8,000 8,000

Net GST received 40,000 40,000 40,000 40,000 40,000

Total cash received 51,050 51,050 50,600 48,000 48,000

Cash used

Grant payments - MREA 761,008 858,576 930,902 859,737 839,792

Grant payments - other 7,839 12,453 12,389 11,623 11,853

Net GST paid 40,000 40,000 40,000 40,000 40,000

Total cash used 808,847 911,029 983,291 911,360 891,645

Net cash from (or used by)

operating activities (757,797) (859,979) (932,691) (863,360) (843,645) Net increase (or decrease) in

cash held (757,797) (859,979) (932,691) (863,360) (843,645)

Cash at beginning of reporting period - - - - -

Cash from Official Public Account for:

- appropriations 757,797 859,979 932,691 863,360 843,645

Cash at end of reporting period - - - - -


522

Documents

Agency Resources and Planned Performance - Health